Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›DoW Lung Cancer Idea Development Award

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

DoW Lung Cancer Idea Development Award

Closes 9/2/2026$400k – $1.2MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The DoW Lung Cancer Idea Development Award supports innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in eradicating deaths and suffering from lung cancer. This mechanism promotes new ideas that are in the early stages of development and have the potential to yield impactful data and new avenues of investigation. Research must address at least one of the FY26 LCRP areas of emphasis. Key aspects of this opportunity include: • The award has a New Investigator category for applicants early in their faculty appointments • Preliminary data to support the feasibility of the research hypotheses and research approaches are required • The award ceiling and floor are not specified • The estimated funding for this opportunity is $6,400,000 • The opportunity is open to unrestricted applicants, subject to any clarification in the text field entitled "Additional Information on Eligibility"

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Danielle Reckley(Help Desk)

[email protected]

(301) 682-5507

Key dates

Opened
5/5/2026
Closes
9/2/2026
Duration
3 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
HT942526LCRPIDA

Budget estimate

$400,000 – $1,200,000

The estimated budget for this opportunity can be estimated based on the estimated funding of $6,400,000. Assuming that this funding will be divided among the awardees, the budget per awardee could be around $800,000, given that there are 8 awards expected. This is a rough estimate and the actual budget could vary depending on the specific requirements and qualifications of the awardees. Factors that may influence the likely payment range include the number of applicants, the quality of the proposals, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

Top match · 79%

DoW Rare Cancers Idea Development Award

Closes 11/18/2026Opened 6/17/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

74% match

DoW Rare Cancers Resource and Community Development Award

Closes 11/18/2026Opened 6/17/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

72% match

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Closes 11/18/2026Opened 8/20/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

72% match

DoW Bone Marrow Failure, Idea Development Award

Closes 11/4/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

71% match

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

Closes 5/30/2029Opened 11/19/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

71% match

DoW Breast Cancer, Clinical Research Extension Award

Closes 11/18/2026Opened 8/20/2026

U.S. National Institutes of Health·United States of America

71% match

Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

Closes 5/26/2029Opened 9/17/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

70% match

DoW Toxic Exposures Clinical Trial Award

Closes 11/19/2026Opened 5/7/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

70% match

DoW Peer Reviewed Cancer, Clinical Trial Award

Rolling / TBD closeOpened 5/6/2026

U.S. Centers for Disease Control and Prevention - ERA·United States of America

70% match

NIOSH Mentored Research Scientist Development Award (K01)

Rolling / TBD closeOpened 9/1/2026

U.S. National Institutes of Health·United States of America

70% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)

Closes 11/7/2028Opened 7/18/2025

U.S. National Institutes of Health·United States of America

69% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

Closes 10/19/2027Opened 12/11/2024

U.S. National Institutes of Health·United States of America

69% match

Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

Closes 1/24/2027Opened 7/16/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

69% match

DoW Reconstructive Transplant, Concept Award

Closes 11/4/2026Opened 5/29/2026

U.S. Centers for Disease Control - NCCDPHP·United States of America

69% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 3/6/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

68% match

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)

Closes 3/12/2029Opened 8/26/2024

U.S. National Institutes of Health·United States of America

68% match

Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration Award

Closes 2/15/2027Opened 7/20/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

68% match

DoW Toxic Exposures Translational Research Award

Closes 11/19/2026Opened 5/7/2026

U.S. National Institutes of Health·United States of America

68% match

NIH Director's Transformative Research Award (R01 Clinical Trial Optional)

Closes 9/2/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

68% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

68% match

DoW Joint Warfighter Medical, Military Medical Research and Development Award

Closes 11/16/2026Opened 6/17/2026

U.S. Food and Drug Administration·United States of America

68% match

Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

68% match

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Closes 2/11/2028Opened 11/7/2024